85
DAFTAR PUSTAKA
Abba, M., Patil, N., & Allgayer, H., 2014. MicroRNAs in the Regulation of MMPs
and Metastasis. Cancers, 6(2), 625–45.
Ali, AY., Farrand, L., Kim, JY., Byun, S., Suh, JY., Lee, HJ., Tsangi, BK. 2012.
Molecular determinants of ovarian cancer chemoresistance: new insights into
an old conundrum. Ann. N.Y. Acad. Sci., 1271, Pages : 58–67
Aziz, FM. 2009. Gynecological Cancer in Indonesia. J Gynecol Oncol, 20(1):pp.8-10
Baranwal, S., & Alahari, S. K., 2010. miRNA control of tumor cell invasion and
metastasis. Int J Cancer126(6): 1283–1290.
Brabletz T .2012.To differentiate or not—routes towards metastasis. Nature Reviews
Cancer 12: 425–436.
Berek, JS; Fu, YS; Hacker, NF. 2002. Ovarian Cancer in Novak’s Gynecology 13th
Edition. Williams & Wilkins, Pensylvania : pp.1245-1320.
Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang
Teilum, M., & Dahlsveen, IK., 2013, Assessing sample and miRNA profile
quality in serum and plasma or other biofluids. Methods, 59(1), S1–6
Bouyssou, JMC., Manier, S., Huynh, D., Issa, S., Roccaro, AM., & Ghobrial, IM.,
2014. Regulation of microRNAs in cancer metastasis.Biochim Biophys Acta,
1845(2), 255–65.
Britton, C., Winter, A. D., Gillan, V., & Devaney, E., 2014, MicroRNAs of Parasitic
Helminths – Identification, Characterization and Potential as Drug Targets. Int
J Parasitol Drugs Drug Resist, 4(2), 85–94.
Buys, SS., Partridge, E., Black, A., et al., 2011. Effect of screening on ovarian cancer
mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening
randomized controlled trial. J Am Med Assoc, 22 : pp.2295– 2302.
Calin, G. a, & Croce, C. M., 2006. MicroRNA signatures in human cancers. Nature
Rev Cancer6(11): 857–66.
Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, et al. (2010). Loss of
miR-200c expression induces an aggressive, invasive, and chemoresistant
phenotype in non–small cell lung cancer. Int J Cancer 8: 1207– 1216.
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
86
Chandi, C. Mandal, A. Nag, S. Kumar. 2015. A Comprehensive Review on miR-
200c, A Promising Cancer Biomarker with Therapeutic Potential.16(12): 1381
– 1403.
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S., 2012, Roles of
microRNA on cancer cell metabolism. J Transl Med, 10, 228.
Chen, H.-C., Chen, G.-H., Chen, Y.-H., Liao, W.-L., Liu, C.-Y., Chang, K.-P., et al.,
2009. MicroRNA deregulation and pathway alterations in nasopharyngeal
carcinoma. Br J Cancer, 100(6): 1002–11.
Chen, Xi., Zhang, Junfeng, Zen, Ke., Zhang, Chen-Yu, 2008, 2011. MicroRNAs as
Blood-based Biomarkers of Cancer. Dalam Cho, C. S. William (Eds).
MicroRNAs in Cancer Translational Research. Springer : Pp.499-532
Chen, Y., Lan, Q., Zheng, T., Zhao, N., Holford, T. R., Lerro, C., et al., 2013.
Polymorphisms in JAK/STAT Signaling Pathway Genes and Risk of Non-
Hodgkin Lymphoma. Leuk Res37(9): 1120–1124.
Chinen, T., Komai, K., Muto, G., Morita, R., Inoue, N., Yoshida, H., et al.,2011.
Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat
Commun,2(2): 190.
Cullen, B. R., 2013. MicroRNAs as Mediators of Viral Immune Evasion Bryan. Nat
Immunol., 14(3): 205–210.
De Martel C., Ferlay J., Franceschi S., 2012. Global Burden of Cancer Attributable to
Infections in 2008: A Review and Synthetic Analysis. Lancet Oncol, 13 :607-
615.
Gao, Y.C. and Wu J. 2015. MicroRNA-200c and microRNA-141 as potential
diagnostic and prognostic biomarkers for ovarian cancer. Tumour biology :
International Society for Oncodevelopmental Biology and Medicine. 36:4843–
4850.
Garzon, R., Marcucci, G., Croce, CM. 2010. Targeting microRNAs in cancer :
rationale, strategies and challenges. Nat Rev Drug Discov, 9(10) : pp.775-789
George, G.P. dan Mittal, R.D. 2010. microRNAs : Potential Biomarker in Cancer.
Indian J Clin Biochem, (1) : pp. 4-14
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
87
Goda G Muralidhar dan Maria V Barbolina. 2015. The miR-200 Family: Versatile
Players in Epithelial Ovarian Cancer. Int. J. Mol. Sci.16 : pp.16833-16847
Hammell, M., Long, D., Zhang, L., Lee, A., Carmack, S., Han, M., et.al. 2008.
mirWIP: microRNA Target Prediction Based on miRNP Enriched Transcripts.
Nat Methods, 5(9) : pp.813–819
Harrison, D.A., 2012. The Jak/STAT pathway. Cold Spring Harb Perspect Biol,4(3):
2012–2015.
Huang, Y., Yang, Y. B., Zhang, X. H., Yu, X. L., Wang, Z. B., et al., 2013.
MicroRNA-21 gene and cancer. Med Oncol30(376).
IAIRC, 2014, World Cancer Report 2014.
Iorio, M. V, & Croce, C. M., 2012. MicroRNA dysregulation in cancer : diagnostics ,
monitoring and therapeutics . A comprehensive review. EMBO Mol Med,
143–159.
Jaime Prat. FIGO’s staging classification for cancer of the ovary, fallopian tube, and
peritoneum: a bridged republication. 2015. Gynecol Oncol, 26 (2) : pp.87-89
Jelovac, D; Armstrong, DK. 2011. Recent Progress in the Diagnosis and treatment of
Ovarian Cancer.Ca Cancer J Clin, 61 : pp.183–203
Kaku, Tsunehisa; Ogawa, Shinji; Kawano, Yfoshiaki; Ohishi, Yoshihiro; Kobayashi,
Hiroaki; Hirakawa, Toshio; Nakano, Hitoo 2003. Histological classification of
ovarian cancer. Med Electron Microsc, 36 : pp.9–17
Kosaka, N., Iguchi, H., & Ochiya, T., 2010. Circulating microRNA in body fluid: a
new potential biomarker for cancer diagnosis and prognosis. Cancer
Sci,101(10): 2087–92.
Krol, J., Loedige, I., & Filipowicz, W., 2010. The widespread regulation of
microRNA biogenesis, function and decay. Nat Rev Genet, 11(9): 597–610.
Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y,
Kinoshita K, Saito S, Baba Y, Baba H. MicroRNA-200b regulates cell
proliferation, invasion, and migration by directly targeting ZEB2 in gastric
carcinoma. Annals of surgical oncology. 2012; 19.3:S656–664.
Lee, A. W. M., Au, J. S. K., Teo, P. M. L., Leung, T. W., Chua, D. T. T., Sze, W. M.,
et al., 2004, Staging of Nasopharyngeal Carcinoma : Suggestions for
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
88
Improving the Current UICC / AJCC Staging System, Clin Oncol (R Coll
Radiol) 1, 269–276.
Lee, Y. S., & Dutta, A., 2010. MicroRNAs in cancer. Annu Rev Pathol (4): 199–227.
Leitner, A., 2009, MicroRNA Target Prediction : Institute of Genomic and
Bioinformatics. Graz University of Technology (Unpublished).
Lima, R. T., Busacca, S., Almeida, G. M., Gaudino, G., Fennell, D. A, &
Vasconcelos, M. H., 2011. MicroRNA regulation of core apoptosis pathways
in cancer. Eur J Cancer,47(2): 163–74.
Lin, Z., & Flemington, E. K., 2011. miRNAs in the pathogenesis of oncogenic human
viruses Zhen. Cancer Lett,305(2): 186–199.
Liu, Michelle X; Chan, David W; Ngan, Hextan YS. 2012. Mechanisms of
Chemoresistance in Human Ovarian Cancer at a Glance. Gynecol Obstet, 2 : 3
Liu, L., Li, W., Wei, X., Cui, Q., Lou, W., Wang, G., et al., 2013. Potent antitumor
activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular
carcinoma. Gene Ther,20(1): 84–92.
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen L, Chen H, Liu J. 2014.miR-200c
Inhibits invasion, migration and proliferation of bladder cancer cells through
down-regulation of BMI-1 and E2F3. Journal of translational medicine.
12:305.
Livak, KJ., Schmittgen, TD. 2001. Analysis of Relative Gene Expression Data Using
Real-Time Quantitative PCR and the 2-∆∆Cq Method. METHODS, 25 : pp. 402–
408
Lodes, MJ; Caraballo, M; Suciu, D; Munro, S; Kumar, A; Anderson, B. 2009.
Detection of cancer with serum miRNAs on an oligonucleotide microarray.
PLoS ONE, 4 : pp.6229
Lu, J., Xu, X., Liu, X., Peng, Y., Zhang, B., Wang, L., et al., 2014. Predictive value
of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis.
Br J Cancer110(2): 392–8.
Mao, F., Leung, WY., Xin, X. 2007. Characterization of EvaGreen and the
implication of its physicochemical properties for qPCR applications. BMC
Biotechnology, 7 : 76
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
89
Menor, M., Ching, T., Zhu, X., Garmire, D., Garmire, LX. 2014. mirMark: a site-
level and UTR-level classifier for miRNA target prediction. Genome Biology,
15 : pp.500
Nakada, C. Matsuura, K. Tsukamoto, Y. Tanigawa, M. Yoshimoto, T. Narimatsu, T.
Nguyen, et al. 2008. Genome-wide microRNA expression profiling in renal
cell carcinoma: significant down-regulation of miR-141 and miR-200c. The
Journal of pathology. 216:418–427.
Ng Ek., Chong W. W.,Jin H. 2009. Differential Expression of microRNAs in Plasma
of Patients with Colorectal Cancer: a Potential marker for Colorectal
Screening. Gut, 58:1375-81.
Nicolleta Colombo. 2014. Optimising the treatment of the partially platinum-sensitive
relapsed ovarian cancer patient. European Journal of Cancer Supplements.
12(2) : pp.7–12
Noonan, E. J., Place, R. F., Li, L. C., 2008, 2011. MicroRNAs in Predicting
Radiotherapy and Chemoterapy Respone. Dalam Cho, C. S. William (Eds).
MicroRNAs in Cancer Translational Research. Springer : Pp.415-448.
Pacurari M, Addison JB, Bondalapati N, Wan Y-W, Luo D. (2013). The microRNA-
200 family targets multiple non-small cell lung cancer prognostic markers in
H1299 cells and BEAS-2B cells. International journal of oncology 43: 548–
560.
Pedro M Costa dan Maria C Pedroso de Lima. 2013. MicroRNAs as Molecular
Targets for Cancer Therapy: On the Modulation of MicroRNA Expression.
Pharmaceuticals, 6(10) : 1195–1220
Pi-Lin, S; Yen-Hou, C; Kuan-Chong, C; Chi-Mu, C. 2014. Global distribution pattern
of histological subtypes of epithelial ovarian cancer: A database analysis and
systematic review. Gynecologic Oncology, 133 : 147–154
Pritchard, CC., Cheng, HH., Tewari, M. 2012. microRNA profiling : approaches and
considerations. Nat Rev. 13 : 358-69
Rosen, DG; Yang, GL; Guangzhi; Mercado-Uribe, I; Chang, B; Xoai, XZ; et.al.
2010. Ovarian cancer: pathology, biology, and disease models. Front Biosci,
14 : 2089-2102
Ruly Widagdo. 2009. Angka Harapan Hidup Penderita Kanker Ovarium di Rumah
Sakit Sardjito. Tesis Fakultas Kedokteran Universitas Gadjah Mada
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
90
Rusnita, T; Prijono, I. Ekspresi P53, Bcl-2 dan Nm23-H1 pada Karsinoma Ovarium
Tipe Serosum dan Musinosum serta Hubungannya dengan Stadium dan
Derajat Histologi. Majalah Patologi; 23(2) : 13-19
Sasi, W., Sharma, A. K., & Mokbel, K., 2014. The role of suppressors of cytokine
signalling in human neoplasms. Mol Biol Int.
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K., 2014. Clinical relevance
of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol, 11(3):145-
56.
Song, C. Liu, L.Z. Pei, X.Q. Liu, X. Yang, L. Ye, F. Xie, X. Chen, J. Tang, H. Xie, X.
2015. miR-200c inhibits breast cancer proliferation by targeting KRAS.
Oncotarget. 6(33):34968-78.
Soslow, A Robert. 2008. Histologic Subtypes of Ovarian Carcinoma: An Overview.
International Journal of Gynecological Pathology, 27 : 161–174
Tang, H,.Deng, M. Tang, Y. Xie, X. Guo, J. Kong, Y. Ye, F. Su, Q. Xie, X. 2013.
miR-200b and miR-200c as prognostic factors and mediators of gastric cancer
cell progression. Clinical cancer research. American Association for Cancer
Research. 19:5602–5612.
Tejero, R., Navarro, A., Campayo, M., Vinolas, N., Marrades, RM.,Cordeiro. A.,
et.al. 2014. miR-141 and miR-200c as Markers of Overall Survival in Early
Stage Non-Small Cell Lung Cancer Adenocarcinoma. PLoS ONE 9(7):
e101899.
Teng, Y. X. Su, X. Zhang, Y. Zhang, C. Li, W. Niu, C. Liu, K.Qu. 2016. miRNA-
200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence
based on miRNA meta-signature and clinical investigations. Oncotarget.
Vester, B dan Wengel, J. 2004. LNA (Locked Nucleic Acid) : High Affinity
Targeting of Complementary RNA and DNA. Biochemistry, 23(42) : 13233-
40
Wang, L., Wang, C., Jin, S., Donghui, Q., Huanchun, Y. 2015. Expression of NF-κB
and PTEN in primary epithelial ovarian carcinoma and the correlation with
chemoresistance. Int J Clin Exp Pathol, 8(9) : 10953-10963
Wang, WT; Zhao, YN; Yan, JX; Weng, MY; Wang, Y; Chen, YQ; et.al. 2014.
Differentially expressed microRNAs in the serum of cervical squamous cell
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
91
carcinoma patients before and after surgery. Journal of Hematology and
Oncology, 7 : 6
Wang, J; Zhang, KY; Liu, SM; Sen, S. 2014. Tumor-Associated Circulating
MicroRNAs as Biomarkers of Cancer. Molecules, 19 : 1912-1938
Wen-Tao, W. dan Chen, Y-Q., 2014, Circulating miRNAs in Cancer : from Detection
to Therapy. Journal of Hematology and Oncology, 7 : 86
William, C.S, Cho. 2011. MicroRNAs in Cancer Translational Research. New York :
Springer.
Yu DS, Lv G, Mei XF, Cao Y, Wang YF, Wang YS, Bi YL. 2014. MiR-200c
regulates ROS-induced apoptosis in murine BV-2 cells by targeting FAP-1.
Spinal cord. 2014.185.
Zeng, X., Xiang, J., Wu, M., Xiong, W., Tang, H., Deng, M., et al., 2012. Circulating
miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive
biomarkers in nasopharyngeal carcinoma. PloS One,7(10).
Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., et al., 2010. Article Secreted
Monocytic miR-150 Enhances Targeted Endothelial Cell Migration. Mol
Cell,39: 133–144.
Zubakov, D.,Boersma, A.W.M., Choi,Y., van Kuijk, P.F., Wiemer, E.A.C., Kayser,
M. 2010. MicroRNA markers for forensic body fluid identification obtained
from microarray screening and quantitative RT-PCR confirmation. Int J Legal
Med,(124):217-226.
PERBEDAAN EKSPRESSI MIR-200c PADA PLASMA ORANG SEHAT, PASIEN TUMOR OVARIUM DANPASIEN KANKER OVARIUM FERDINANDUS K PUKAN, Prof. dr. Sofia Mubarika H., M.Med.Sc., Ph.D.; Dr. Med. dr. Indwiani Astuti Universitas Gadjah Mada, 2017 | Diunduh dari http://etd.repository.ugm.ac.id/
Top Related